# US 2013/0156738 A1 · Bifidobacterium adolescentis spm0212 having antiviral activity for hepatitis b virus, and pharmaceutical composition for preventing and treating hepatitis b comprising thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156738 A1
- Document ID: US20130156738A1
- Status: Published application
- Kind: A1
- Application number: 13/336,159
- Filed: 2011-12-23
- Published: 2013-06-20
- Earliest claimed: 2011-12-16
- Assignees: Sahmyook University
- Inventors: Nam Joo HA; Kang Oh LEE; Do Kyung Lee
- Web page: https://patentgrep.com/patent/US20130156738A1

## CPC

- A61K 35/745: Bifidobacteria
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 31/12: Antivirals
- A61P 31/20: for DNA viruses
- C12N 1/20: Bacteria; Culture media therefor
- C12N 1/205: Bacterial isolates
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to a bifidobacterium adolescentis SPMO212 having antiviral activity for hepatitis B virus, and a pharmaceutical composition for preventing and treating hepatitis B comprising thereof. The bifidobacterium adolescentis SPMO212 or its fraction of the present invention shows antiviral activity for hepatitis B virus by blocking the production of antigen s of hepatitis B virus, and by inhibiting the expression of DNA, RNA and HBsAg of the HBV.

## Claims

### Claim 1

An isolated bifidobacterium adolescentis SPMO212 (Accession No.: KCTC 18120P) showing having antiviral activity for hepatitis B virus.

### Claim 2 (depends on 1)

The bifidobacterium adolescentis SPMO212 (Accession No.: KCTC 18120P) of claim 1, which inhibits the production of antigen s of hepatitis B virus, and the expression of DNA, RNA and HBsAg of the hepatitis B virus.

### Claim 3 (depends on 1)

A pharmaceutical composition for preventing and treating hepatitis B comprising the bifidobacterium adolescentis SPMO212 of claim 1 or culture thereof.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the bifidobacterium adolescentis SPMO212 inhibits the production of antigen s of hepatitis B virus, and the expression of DNA, RNA and HBsAg of the hepatitis B virus.

### Claim 5 (depends on 3)

The composition of claim 3, which further comprises lamivudine.

### Claim 6 (depends on 1)

A health functional food for preventing and improving hepatitis B comprising the bifidobacterium adolescentis SPMO212 of claim 1 or culture thereof.

### Claim 7 (depends on 6)

The health functional food for preventing and improving hepatitis B of claim 6, wherein the bifidobacterium adolescentis SPMO212 inhibits the production of antigen s of hepatitis B virus, and the expression of DNA, RNA and HBsAg of the hepatitis B virus.

### Claim 8 (depends on 1)

A method for inhibiting production of antigen s of hepatitis B virus, and the expression of DNA, RNA and HBsAg of the hepatitis B virus comprising: administrating a pharmaceutical composition comprising the bifidobacterium adolescentis SPMO212 (Accession No.: KCTC 18120P) of claim 1 or culture thereof as to a subject in need thereof.

### Claim 9 (depends on 1)

A method for preventing and treating hepatitis B comprising: administrating a pharmaceutical composition comprising the bifidobacterium adolescentis SPMO212 of claim 1 or culture thereof to a subject in need thereof.

### Claim 10 (depends on 1)

A method for preventing and treating hepatitis B comprising: administrating lamivudine and a pharmaceutical composition comprising the bifidobacterium adolescentis SPMO212 of claim 1 or culture thereof to a subject in need thereof.
